BioCentury | Dec 22, 2016
Politics & Policy

Senate price gouging panel doesn’t recommend price controls

...Turing Pharmaceuticals AG (Zug, Switzerland), Retrophin Inc. (NASDAQ:RTRX), Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) and Rodelis Therapeutics...
...burden drug prices are placing on hard-working Americans" (see BioCentury Extra, Dec. 20) . Becky Simon Retrophin Inc. Rodelis Therapeutics Turing...
BioCentury | Nov 5, 2015
Top Story

Democrats attack drug prices

...hearing on the topic. The committee sent letters to Valeant, Turing, Retrophin Inc. (NASDAQ:RTRX), and Rodelis Therapeutics...
BioCentury | Sep 28, 2015
Company News

The Chao Center, Rodelis Therapeutics deal

...of cycloserine. The Chao Center for Industrial Pharmacy & Contract Manufacturing , West Lafayette, Ind. Rodelis Therapeutics...
BioCentury | Sep 23, 2015
Company News

Non-profit reacquires rights to TB drug after price hike

...Foundation (West Lafayette, Ind.), reacquired rights to Seromycin cycloserine, an antibiotic to treat tuberculosis, from Rodelis Therapeutics...
Items per page:
1 - 4 of 4
BioCentury | Dec 22, 2016
Politics & Policy

Senate price gouging panel doesn’t recommend price controls

...Turing Pharmaceuticals AG (Zug, Switzerland), Retrophin Inc. (NASDAQ:RTRX), Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) and Rodelis Therapeutics...
...burden drug prices are placing on hard-working Americans" (see BioCentury Extra, Dec. 20) . Becky Simon Retrophin Inc. Rodelis Therapeutics Turing...
BioCentury | Nov 5, 2015
Top Story

Democrats attack drug prices

...hearing on the topic. The committee sent letters to Valeant, Turing, Retrophin Inc. (NASDAQ:RTRX), and Rodelis Therapeutics...
BioCentury | Sep 28, 2015
Company News

The Chao Center, Rodelis Therapeutics deal

...of cycloserine. The Chao Center for Industrial Pharmacy & Contract Manufacturing , West Lafayette, Ind. Rodelis Therapeutics...
BioCentury | Sep 23, 2015
Company News

Non-profit reacquires rights to TB drug after price hike

...Foundation (West Lafayette, Ind.), reacquired rights to Seromycin cycloserine, an antibiotic to treat tuberculosis, from Rodelis Therapeutics...
Items per page:
1 - 4 of 4